Your browser doesn't support javascript.
loading
EBV-driven lymphoid neoplasms associated with pediatric ALL maintenance therapy.
Elitzur, Sarah; Vora, Ajay; Burkhardt, Birgit; Inaba, Hiroto; Attarbaschi, Andishe; Baruchel, Andre; Escherich, Gabriele; Gibson, Brenda; Liu, Hsi-Che; Loh, Mignon; Moorman, Anthony V; Möricke, Anja; Pieters, Rob; Uyttebroeck, Anne; Baird, Susan; Bartram, Jack; Barzilai-Birenboim, Shlomit; Batra, Sandeep; Ben-Harosh, Miriam; Bertrand, Yves; Buitenkamp, Trudy; Caldwell, Kenneth; Drut, Ricardo; Geerlinks, Ashley V; Gilad, Gil; Grainger, John; Haouy, Stephanie; Heaney, Nicholas; Huang, Mary; Ingham, Danielle; Krenova, Zdenka; Kuhlen, Michaela; Lehrnbecher, Thomas; Manabe, Atsushi; Niggli, Felix; Paris, Claudia; Revel-Vilk, Shoshana; Rohrlich, Pierre; Sinno, Mohamad G; Szczepanski, Tomasz; Tamesberger, Melanie; Warrier, Rajasekharan; Wolfl, Matthias; Nirel, Ronit; Izraeli, Shai; Borkhardt, Arndt; Schmiegelow, Kjeld.
Affiliation
  • Elitzur S; Department of Pediatric Hematology and Oncology, Schneider Children's Medical Center and Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Vora A; Department of Paediatric Haematology, Great Ormond Street Hospital, London, United Kingdom.
  • Burkhardt B; Pediatric Hematology and Oncology, University Hospital Münster, Münster, Germany.
  • Inaba H; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN.
  • Attarbaschi A; Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria.
  • Baruchel A; Department of Pediatric Hematology, Hôpital Robert Debré, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
  • Escherich G; Department of Pediatric Hematology and Oncoogy, University Medical Centre, Hamburg-Eppendorf, Hamburg, Germany.
  • Gibson B; Department of Paediatric Haematology, Royal Hospital for Children, Glasgow, United Kingdom.
  • Liu HC; Division of Pediatric Hematology/Oncology, Mackay Children's Hospital and Mackay Medical College, Taipei, Taiwan.
  • Loh M; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant and Cellular Therapy, Seattle Children's Hospital and the Ben Towne Center for Childhood Cancer Research, University of Washington, Seattle, WA.
  • Moorman AV; Leukaemia Research Cytogenetics Group, Wolfson Childhood Cancer Centre, Clinical and Translational Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Möricke A; Department of Pediatrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Pieters R; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Uyttebroeck A; Department of Paediatric Haematology and Oncology, University Hospital Leuven, Leuven, Leuven, Belgium.
  • Baird S; Department of Haematology, Royal Hospital for Children and Young People, Edinburgh, United Kingdom.
  • Bartram J; Department of Paediatric Haematology, Great Ormond Street Hospital, London, United Kingdom.
  • Barzilai-Birenboim S; Department of Pediatric Hematology and Oncology, Schneider Children's Medical Center and Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Batra S; Pediatric Hematology/Oncology, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN.
  • Ben-Harosh M; Department of Pediatric Hemato-Oncology, Soroka Medical Center, Ben-Gurion University of the Negev, Beer Sheva, Israel.
  • Bertrand Y; Institut d'Hematologie et d'Oncologie Pediatrique, Hospices Civils de Lyon, Lyon, France.
  • Buitenkamp T; Amsterdam Academic Medical Center, Emma Children's Hospital, Amsterdam, The Netherlands.
  • Caldwell K; Cancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St Petersburg, FL.
  • Drut R; Department of Pathology, School of Medicine, La Plata National University, La Plata, Argentina.
  • Geerlinks AV; Children's Hospital, Western University, London, ON, Canada.
  • Gilad G; Department of Pediatric Hematology and Oncology, Schneider Children's Medical Center and Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Grainger J; Faculty of Medical & Human Sciences, University of Manchester and Royal Manchester Children's Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
  • Haouy S; Department of Pediatric Oncology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
  • Heaney N; Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
  • Huang M; Department of Pediatric Hematology Oncology, Massachusetts General Hospital for Children, Harvard Medical School, Boston, MA.
  • Ingham D; Paediatric Oncology, Leeds Children's Hospital, Leeds, United Kingdom.
  • Krenova Z; Department of Pediatric Oncology and Department of Pediatrics, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Kuhlen M; Pediatrics and Adolescent Medicine, University of Augsburg, Augsburg, Germany.
  • Lehrnbecher T; Pediatric Hematology and Oncology, Hospital for Children and Adolescents, Johann Wolfgang Goethe University, Frankfurt, Germany.
  • Manabe A; Department of Pediatrics, Hokkaido University, Graduate School of Medicine, Sapporo, Japan.
  • Niggli F; Department of Pediatric Oncology, University Children's Hospital, Zurich, Switzerland.
  • Paris C; Department of Pediatric Oncology and Hematology, Hospital Luis Calvo Mackenna, Santiago, Chile.
  • Revel-Vilk S; Shaare Zedek Medical Centre and The Faculty of Medicine, Hebrew University, Jerusalem, Israel.
  • Rohrlich P; Pediatric Oncology, Nice University Hospital, Nice, France.
  • Sinno MG; Phoenix Children's Hospital, Center for Cancer and Blood Disorders, Phoenix, AZ.
  • Szczepanski T; Department of Pediatric Hematology and Oncology, Zabrze and Medical University of Silesia, Katowice, Poland.
  • Tamesberger M; Department of Pediatrics and Adolescent Medicine, Kepler University Clinic, Linz, Austria.
  • Warrier R; Pediatric Hematology/Oncology, Ochsner Children's Hospital, New Orleans, LA.
  • Wolfl M; Pediatric Oncology, Hematology and Stem Cell Transplantation Program, University Children's Hospital Würzburg, Würzburg, Germany.
  • Nirel R; Department of Statistics and Data Science, Hebrew University, Jerusalem, Israel.
  • Izraeli S; Department of Pediatric Hematology and Oncology, Schneider Children's Medical Center and Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Borkhardt A; Department of Paediatric Oncology, Haematology and Clinical Immunology, Medical Faculty, Heinrich-Heine University, Duesseldorf, Germany.
  • Schmiegelow K; Department of Pediatrics and Adolescent Medicine, The University Hospital, Rigshospitalet, and Institute of Clinical Medicine, Faculty of Medicine, University of Copenhagen, Copenhagen, Denmark.
Blood ; 141(7): 743-755, 2023 02 16.
Article in En | MEDLINE | ID: mdl-36332176
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Neoplasms, Second Primary / Epstein-Barr Virus Infections / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Lymphoma Type of study: Risk_factors_studies / Screening_studies Limits: Child / Humans Language: En Journal: Blood Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Neoplasms, Second Primary / Epstein-Barr Virus Infections / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Lymphoma Type of study: Risk_factors_studies / Screening_studies Limits: Child / Humans Language: En Journal: Blood Year: 2023 Document type: Article Affiliation country: Country of publication: